1.
Yao F, Shi Z. MiR-16 is promising to be a therapy target to alleviate atherosclerosis. DT [Internet]. 2023 Jan. 16 [cited 2024 Dec. 25];2(1):13-5. Available from: https://ojs.luminescience.cn/DT/article/view/161